ArticleKidney diseases (Basel, Switzerland)

The Clinical Efficacy Evaluation of the KHA-200 Hemoperfusion Device in the Treatment of End-Stage Renal Disease Patients Undergoing Blood Purification Therapy.

Qing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.